News

Recent News

Watch the trailer #SHEROTalks premieres November 20th, 2019 at 6PM, Live on Facebook.

November 15, 2019

 

In honor of national Transgender Day of Remembrance, the Multicultural AIDS Coalition & Harvard University Center for AIDS Research is excited to present the debut of SHERO Talks: Virtual Journal Club Series. SHERO Talks, is a podcast series where trans women of color speak on their health,...

Read more about Watch the trailer #SHEROTalks premieres November 20th, 2019 at 6PM, Live on Facebook.

Drs. Goldstein and Walensky publish a perspective in the NEJM "Where Were the Women? Gender Parity in Clinical Trials"

October 31, 2019

Robert H. Goldstein, M.D., Ph.D., and Rochelle P. Walensky, M.D., M.P.H. explain what happened with the Gilead Sciences DISCOVER trial and why it failed cisgender women and people everywhere.

From the article:
"Two months after its approval for treatment, F/TAF’s manufacturer, Gilead Sciences, moved forward with an effort to expand the drug’s indications to include prevention of HIV infection. To do so, they collaborated with researchers, community members, and the FDA to develop a new preexposure prophylaxis trial protocol — the DISCOVER trial — and to work...

Read more about Drs. Goldstein and Walensky publish a perspective in the NEJM "Where Were the Women? Gender Parity in Clinical Trials"

Reflections on IAS 2019 from a Differentiated Service Delivery Perspective by Dr. Ingrid Bassett

September 30, 2019

Dr. Ingrid Bassett, HU CFAR Developmental and Mentoring Core Director, was a plenary speaker at IAS 2019 in Mexico City. 

"The 10th IAS Conference on HIV Science (IAS 2019) was notable to me for two reasons. Firstly, it was a shift away from the 90-90-90 national targets to a more nuanced awareness of which populations are not being reached with existing HIV services. Secondly, differentiated service delivery (DSD) models were applied not...

Read more about Reflections on IAS 2019 from a Differentiated Service Delivery Perspective by Dr. Ingrid Bassett

Training Opportunity: Apply for Inter-CFAR Implementation Science Fellowship for Early Stage Investigators

September 25, 2019

Inter-CFAR Fellowship Program in Implementation Science for Early-Stage HIV Investigators

 

Collaborating CFARs: Johns Hopkins University, University of North Carolina, University of California San Francisco/GIVI, Emory University, Third Coast CFAR – Northwestern, Harvard University, University of Washington,...

Read more about Training Opportunity: Apply for Inter-CFAR Implementation Science Fellowship for Early Stage Investigators

Apply Now: HU CFAR RFPs for awards beginning February 2020

August 21, 2019

The HU CFAR is pleased to announce a general and special emphasis RFP for the latest cycle of Developmental Core awards to begin February 2020.  General awards may request up to $60k in direct costs.  Special emphasis awards around the topic of Community Engaged Research to Address HIV Prevention, Care and Treatment Challenges may request up to $100k in direct costs.

Take advantage of an expert pre-review to strenghten your application.  Pre-review and consultation is also available from a number of HU CFAR faculty from...

Read more about Apply Now: HU CFAR RFPs for awards beginning February 2020

NEW FOA from FIC; NIDA; NIMH; NCI: "Reducing Stigma to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle-Income Countries" (R21 Clinical Trial Optional)

August 7, 2019

FOA was recently published on Stigma, “Reducing Stigma to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle-Income Countries (R21 Clinical Trial Optional)” https://grants.nih.gov/grants/guide/pa-files/PAR-19-326.html

... Read more about NEW FOA from FIC; NIDA; NIMH; NCI: "Reducing Stigma to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle-Income Countries" (R21 Clinical Trial Optional)
More